These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25199865)

  • 1. [Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].
    de Crevoisier R; Castelli J; Guérif S; Pommier P; Créhange G; Chauvet B; Lagrange JL
    Cancer Radiother; 2014 Oct; 18(5-6):369-78. PubMed ID: 25199865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate cancer external beam radiotherapy].
    de Crevoisier R; Pommier P; Latorzeff I; Chapet O; Chauvet B; Hennequin C
    Cancer Radiother; 2016 Sep; 20 Suppl():S200-9. PubMed ID: 27516051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the level of evidence of new techniques in prostate cancer radiotherapy?].
    Khadige M; Peiffert D; Supiot S
    Cancer Radiother; 2014 Oct; 18(5-6):501-8. PubMed ID: 25192625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
    Kaidar-Person O; Roach M; Créhange G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.
    Meijer HJ; Debats OA; Kunze-Busch M; van Kollenburg P; Leer JW; Witjes JA; Kaanders JH; Barentsz JO; van Lin EN
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):175-83. PubMed ID: 21075555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
    Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
    Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer: doses and volumes of radiotherapy].
    Hennequin C; Rivera S; Quero L; Latorzeff I
    Cancer Radiother; 2010 Oct; 14(6-7):474-8. PubMed ID: 20728390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
    McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative radiotherapy of prostate cancer].
    Guérif S; Latorzeff I; Lagrange JL; Hennequin C; Supiot S; Garcia A; François P; Soulié M; Richaud P; Salomon L
    Cancer Radiother; 2014 Oct; 18(5-6):517-23. PubMed ID: 25195116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT.
    Schild MH; Schild SE; Wong WW; Vora SA; Keole SR; Vargas CE; Daniels TB; Ezzell GA; Nguyen BD; Roarke MC
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1021-1025. PubMed ID: 28332984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intensity-modulated radiotherapy in head and neck cancer: ethics and methodology].
    Lapeyre M; Biau J; Miroir J; Servagi-Vernat S; Giraud P
    Cancer Radiother; 2014 Oct; 18(5-6):365-8. PubMed ID: 25179256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.
    Bayley A; Rosewall T; Craig T; Bristow R; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):477-83. PubMed ID: 19733014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External radiotherapy for prostatic cancers.
    de Crevoisier R; Supiot S; Créhange G; Pommier P; Latorzeff I; Chapet O; Pasquier D; Blanchard P; Schick U; Marchesi V; Sargos P; Hennequin C
    Cancer Radiother; 2022; 26(1-2):329-343. PubMed ID: 34955419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.
    Patel N; Faria S; Cury F; David M; Duclos M; Shenouda G; Ruo R; Souhami L
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):534-9. PubMed ID: 23597418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of rectal carcinoma].
    Peiffert D; Créhange G; Vendrely V; Baumann AS; Faivre JC; Huger S; Serre AA
    Cancer Radiother; 2016 Sep; 20 Suppl():S179-82. PubMed ID: 27523414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moderate or extreme hypofractionation and localized prostate cancer: The times are changing].
    Line Krhili S; Créhange G; Albert-Dufrois H; Guimas V; Minsat M; Supiot S
    Cancer Radiother; 2019 Oct; 23(6-7):503-509. PubMed ID: 31471253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.